ZLDPF
Price:
$77.78
Market Cap:
$35.95B
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company's pipeline includes Dasiglucagon that is in Phase III clinical trials fo...[Read more]
Industry
Biotechnology
IPO Date
2013-02-25
Stock Exchange
OTC
Ticker
ZLDPF
According to Zealand Pharma A/S’s latest financial reports and current stock price. The company's current PE Ratio is 5.47. This represents a change of -117.69% compared to the average of -30.93 of the last 4 quarters.
The mean historical PE Ratio of Zealand Pharma A/S over the last ten years is -16.59. The current 5.47 PE Ratio has changed -3397.42% with respect to the historical average. Over the past ten years (40 quarters), ZLDPF's PE Ratio was at its highest in in the September 2023 quarter at 60.11. The PE Ratio was at its lowest in in the September 2024 quarter at -53.91.
Average
-16.59
Median
-11.96
Minimum
-44.06
Maximum
4.38
Discovering the peaks and valleys of Zealand Pharma A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 211.43%
Maximum Annual PE Ratio = 4.38
Minimum Annual Increase = -417.69%
Minimum Annual PE Ratio = -44.06
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -44.06 | 46.82% |
| 2023 | -30.01 | 211.43% |
| 2022 | -9.64 | 57.72% |
| 2021 | -6.11 | -38.88% |
| 2020 | -10.00 | -28.20% |
| 2019 | -13.92 | -417.69% |
| 2018 | 4.38 | -148.35% |
| 2017 | -9.06 | -46.12% |
| 2016 | -16.82 | -45.12% |
| 2015 | -30.65 | 6.06% |
The current PE Ratio of Zealand Pharma A/S (ZLDPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.90
5-year avg
-19.96
10-year avg
-16.59
Zealand Pharma A/S’s PE Ratio is less than ALK-Abelló A/S (49.80), greater than Shanghai Junshi Biosciences Co., Ltd. (-38.88), greater than InnoCare Pharma Limited (-75.65), less than H. Lundbeck A/S (12.80), less than Laboratorios Farmaceuticos Rovi, S.A. (23.16), greater than Genscript Biotech Corporation (0.73), less than Hikma Pharmaceuticals PLC (12.79), less than Hikma Pharmaceuticals PLC (12.79), less than H. Lundbeck A/S (12.80), less than Camurus AB (publ) (46.11),
| Company | PE Ratio | Market cap |
|---|---|---|
| 49.80 | $7.26B | |
| -38.88 | $5.81B | |
| -75.65 | $3.18B | |
| 12.80 | $5.31B | |
| 23.16 | $4.63B | |
| 0.73 | $4.62B | |
| 12.79 | $4.65B | |
| 12.79 | $4.71B | |
| 12.80 | $5.50B | |
| 46.11 | $3.83B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zealand Pharma A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zealand Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Zealand Pharma A/S's PE Ratio?
How is the PE Ratio calculated for Zealand Pharma A/S (ZLDPF)?
What is the highest PE Ratio for Zealand Pharma A/S (ZLDPF)?
What is the 3-year average PE Ratio for Zealand Pharma A/S (ZLDPF)?
What is the 5-year average PE Ratio for Zealand Pharma A/S (ZLDPF)?
How does the current PE Ratio for Zealand Pharma A/S (ZLDPF) compare to its historical average?